Bone Marrow TransplantationBone TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousBone and BonesWhole-Body IrradiationLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningKidney TransplantationGraft SurvivalAnemia, AplasticTissue DonorsTransplantation ChimeraLeukemiaHistocompatibility TestingBusulfanBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicGraft RejectionHematopoietic Stem CellsHeart TransplantationCyclophosphamideImmunosuppressive AgentsBone RemodelingBone Marrow DiseasesRecurrenceTreatment OutcomeLung TransplantationHematopoiesisCombined Modality TherapyTransplantation ImmunologyStem Cell TransplantationTime FactorsMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsLeukemia, Myeloid, AcuteImmunosuppressionBone Marrow ExaminationRemission InductionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone DensityGraft vs Host ReactionRetrospective StudiesAcute DiseaseLeukemia, MyeloidLymphocyte DepletionBone Marrow NeoplasmsCyclosporineLeukocyte TransfusionSurvival AnalysisLymphoma, Non-HodgkinHLA AntigensOrgan TransplantationT-LymphocytesSevere Combined ImmunodeficiencyChimeraMyelodysplastic SyndromesTransplantationBone ResorptionColony-Forming Units AssayActuarial AnalysisFollow-Up StudiesHematologic DiseasesCytomegalovirus InfectionsLymphocyte TransfusionSurvival RateAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCell TransplantationIslets of Langerhans TransplantationCell DifferentiationCarmustineGraft vs Tumor EffectLiving DonorsGraft vs Leukemia EffectCord Blood Stem Cell TransplantationPancytopeniaPancreas TransplantationCytarabineLeukocyte CountDisease-Free SurvivalMelphalanPostoperative ComplicationsGranulocyte Colony-Stimulating FactorBone NeoplasmsMice, Inbred BALB CAntilymphocyte SerumMultiple MyelomaTransplantation ToleranceSpleenLymphomaFlow Cytometry